company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,535197.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,797935.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1333132.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1333132.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4591.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4591.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1328541.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1328541.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1328541.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1328541.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18043385.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 16:17:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,408374.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,500091.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,908465.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-908465.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4480.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4480.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-903985.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-903985.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-903985.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-903985.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18821881.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:31:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,615297.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,903953.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1519250.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1519250.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2114.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2114.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1517136.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1517136.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1517136.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1517136.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19922057.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 16:16:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,491828.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,905635.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1397463.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1397463.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3312.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3312.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1394151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1394151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1394151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1394151.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23200000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23200000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21654680.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q2,2011-04-01,2011-06-30,2011-08-15 16:17:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,516873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,614137.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1131010.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1131010.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3169.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3169.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1127841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1127841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1127841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1127841.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21654680.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 16:31:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1074176.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,960240.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2034416.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2034416.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2390.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-319908.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-317518.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2351934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2351934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2351934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2351934.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21728292.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,637383.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,727327.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1364710.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1364710.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1317.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,274207.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,275524.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1089186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1089186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1089186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1089186.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27200000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27200000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24710362.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q1,2012-01-01,2012-03-31,2012-05-15 16:16:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,534623.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,532741.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1067364.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1067364.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1365.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,776919.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,778284.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-289080.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-289080.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-289080.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-289080.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28900000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28900000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26851410.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q2,2012-04-01,2012-06-30,2012-08-14 16:36:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,628876.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,654837.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1283713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1283713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2744.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1340566.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1337822.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2621535.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2621535.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2621535.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2621535.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32800000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32132824.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 16:38:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,760661.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,744692.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1505353.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1505353.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5426.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1434194.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1428768.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-76585.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-76585.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-76585.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-76585.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30033108.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,613129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1092301.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1705430.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1705430.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6467.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-45326.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38859.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1744289.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1744289.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1744289.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1744289.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41420687.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q1,2013-01-01,2013-03-31,2013-05-15 16:18:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,521491.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2132038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2653529.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2653529.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8526.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-498587.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-490061.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3143590.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3143590.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3143590.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3143590.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39300000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39300000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41445413.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q2,2013-04-01,2013-06-30,2013-08-14 17:33:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,441424.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2804352.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3245776.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3245776.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10318.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2676601.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2666283.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5912059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5912059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5912059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5912059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45500000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45500000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44686310.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q3,2013-07-01,2013-09-30,2013-11-13 16:30:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,638840.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2068083.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2706923.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2706923.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-25311.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1377576.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1352265.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1354658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1354658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1354658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1354658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45452447.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,759682.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2748683.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3508365.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3508365.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32760.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-335514.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-302754.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3811119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3811119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3811119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3811119.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54400000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54400000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54138580.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 16:26:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,891215.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2098958.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2990173.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2990173.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-207847.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-207847.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3198020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3198020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3198020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3198020.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66167556.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:08:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1223137.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2885892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4109029.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4109029.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-900863.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-900863.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5009892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5009892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5009892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5009892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67169383.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1599620.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2384241.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3983861.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3983861.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-32760.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,526591.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,493831.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3490030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3490030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3490030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3490030.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64142534.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1942363.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2349552.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4291915.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4291915.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1118344.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1118344.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5410259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5410259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5410259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5410259.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77300000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77300000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76039220.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:17:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2319822.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2577508.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4897330.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4897330.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,338827.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,338827.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4558503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4558503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4558503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4558503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82037560.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1974757.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3042671.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5017428.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5017428.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,568390.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,568390.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4449038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4449038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4449038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4449038.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82470139.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:11:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2360068.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3831611.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6191679.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6191679.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,376521.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,376521.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5815158.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5815158.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5815158.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5815158.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80900000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80900000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80858393.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2691145.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3546391.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6237536.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6237536.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,851299.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,851299.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5386237.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5386237.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5386237.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5386237.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76900000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76900000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82860083.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:23:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2305555.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2508897.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4814452.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4814452.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,245538.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,245538.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4568914.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4568914.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4568914.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4568914.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82870649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1420015.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2493999.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3914014.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3914014.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39967.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39967.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3953981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3953981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3953981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3953981.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82870649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:32:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1493545.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2820654.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4314199.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4314199.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150879.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,150879.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4163320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4163320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4163320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4163320.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82100000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82875281.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1865942.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2813929.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4679871.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4679871.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-287258.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-287258.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4967129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4967129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4967129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4967129.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82800000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82800000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82972316.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1729520.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2451751.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4181271.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4181271.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,301370.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,301370.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3879901.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3879901.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3879901.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3879901.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83905827.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1601785.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2704923.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4306708.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4306708.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,129059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,129059.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4177649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4177649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4177649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4177649.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84797969.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:08:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2107152.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3404634.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5511786.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5511786.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,124088.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,124088.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5387698.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5387698.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5387698.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5387698.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87700000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87700000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85802487.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2674398.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3259042.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5933440.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5933440.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,233548.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,233548.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5699892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5699892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5699892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5699892.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102557350.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 17:16:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2631031.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3704824.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6335855.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6335855.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,370715.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,370715.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5965140.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5965140.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5965140.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5965140.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102596446.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102596446.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99400000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:09:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3644234.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4538369.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8182603.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8182603.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,343730.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,343730.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7838873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7838873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7838873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7838873.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102641504.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102641504.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:33:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,500000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,500000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,500000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6926298.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8416969.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15343267.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14843267.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,343658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,343658.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14499609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14499609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14499609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14499609.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102633884.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102633884.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103000000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12448438.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12448438.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1711788.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1711788.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10736650.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8416460.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3307959.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11724419.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-987769.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,343266.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,343266.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-644503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-644503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-644503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-644503.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102747923.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102747923.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64500000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:06:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28837900.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28837900.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4261625.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4261625.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24576275.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8987722.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4629364.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13617086.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10959189.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,450410.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,450410.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11409599.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,449651.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10959948.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10959948.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10959948.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102869202.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105928970.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99600000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:09:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30897444.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30897444.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4387461.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4387461.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26509983.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8067792.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4597039.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12664831.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13845152.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,393415.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,393415.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14238567.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,608388.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13630179.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13630179.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13630179.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102974105.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107045234.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104800000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:33:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30122555.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30122555.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4398265.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4398265.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25724290.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11409213.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6308390.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17717603.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8006687.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,398683.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,398683.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8405370.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,475657.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7929713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7929713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7929713.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102944316.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106020936.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102800000.0
Catalyst Pharmaceuticals Inc,CPRX,,0001369568,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
